Jude Weber

Anu Adeoye, acting Global Pharmaceuticals correspondent at the Financial Times, and Jude Weber, the paper's Ireland correspondent, dive into pressing industry and geopolitical topics. They discuss promising clinical trial results amid Bayer's challenges and Novo Nordisk’s disappointing Alzheimer's drug failure. Weber highlights how Ireland's military neutrality has left it vulnerable, particularly concerning transatlantic undersea cables, and outlines the limitations of its defense capabilities. Both guests speculate on the future of Ireland’s defense stance.